Delayed
Japan Exchange
11:30:00 26/04/2024 am IST
5-day change
1st Jan Change
5,543
JPY
-0.66%
+0.71%
-18.37%
Sales 2024 *
185B
1.17B
97.59B
Sales 2025 *
193B
1.22B
102B
Capitalization
411B
2.6B
217B
Net income 2024 *
21.36B
135M
11.25B
Net income 2025 *
22.03B
139M
11.6B
EV / Sales 2024 *
1.75
x
Net cash position
2024
*
86.04B
544M
45.3B
Net cash position
2025
*
93.53B
591M
49.24B
EV / Sales 2025 *
1.65
x P/E ratio 2024 *
19.4
x
P/E ratio 2025 *
18.7
x
Employees
3,534
Yield 2024 *
1.86%
Yield 2025 *
1.89%
Free-Float
59.84%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
A second Kobayashi Pharma Japan factory inspected over deaths
31/03
RE
Kobayashi factory searched over deaths possibly linked to supplements
30/03
RE
Kobayashi Pharmaceutical Recalls 'Beni-Koji' Supplement Following Report of Death, Kidney Damage
27/03
MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.
08/11
CI
Kobayashi Pharmaceutical Co., Ltd's Equity Buyback announced on November 7, 2023, has closed with 1,924,600 shares, for ¥11,999.88 million.
08/11
CI
Kobayashi Pharmaceutical Co., Ltd. acquired Focus Consumer Healthcare, LLC.
07/23/07
CI
Kobayashi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
10/23/10
CI
Organ Technologies Inc announced that it has received funding from Kobayashi Pharmaceutical Co., Ltd.
10/23/10
CI
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.
02/22/02
CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 1, 2022, has closed with 1,150,602 shares, representing 1.49% for ¥9,991.92 million.
02/22/02
CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million.
01/22/01
CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
01/22/01
CI
Kobayashi Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2022
04/22/04
CI
UBS Adjusts Kobayashi Pharmaceutical's Price Target to 12,600 Yen From 13,100 Yen, Keeps at Buy
03/22/03
MT
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.
14/22/14
CI
More news
1 day -0.66%
1 week +0.71%
Current month +8.79%
1 month +13.01%
3 months -18.53%
6 months -10.91%
Current year -18.37%
More quotes
Managers
Title Age Since
Chairman
84
01/62/01
Director of Finance/CFO
-
-
President
52
01/98/01
Members of the board
Title Age Since
Director/Board Member
91
01/08/01
President
52
01/98/01
Chairman
84
01/62/01
More insiders
Date
Price
Change
Volume
26/24/26
5,543
-0.66%
990,600
25/24/25
5,580
-0.61%
817,500
24/24/24
5,614
-1.13%
1,215,700
23/24/23
5,678
-0.32%
1,168,300
22/24/22
5,696
+3.49%
1,719,500
Delayed Quote
Japan Exchange, April 26, 2024 at 11:30 am IST
More quotes
KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.
More about the company
Last Close Price
5,543
JPY
Average target price
8,182
JPY
Spread / Average Target
+47.60%
Consensus
1st Jan change
Capi.
-18.37% 2.61B +8.76% 129B +14.18% 74.67B -16.59% 62.59B +0.82% 52.86B -12.40% 36.11B +3.54% 33.57B +7.92% 17.29B +6.30% 14.75B -8.65% 10.82B
Other Personal Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1